The Patent Finder

Schwarz Pharma Ltd.

Also on record
Records under this name other than the patents Schwarz Pharma Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Back to Schwarz Pharma Ltd.

PatentTitleStatus Expires Confidence
US 8,344,176Synthesis of substituted hydroxymethyl phenols
Lapsed on the fee record
Ended Jan 1, 2025 · From the USPTO record
Lapsed on the fee recordEnded Jan 1, 2025From the USPTO record
US 8,299,306Accelerated synthesis of substituted hydroxymethyl phenols
Formerly held
Lapsed on the fee record
Ended Oct 30, 2024 · From the USPTO record
Lapsed on the fee recordEnded Oct 30, 2024From the USPTO record
US 10,251,844Transdermal therapeutic system and method of use thereof for treating parkinsonism
Formerly held
Term ended
Term ended Feb 25, 2024 · From the USPTO record
Term endedTerm ended Feb 25, 2024From the USPTO record
US 8,115,028Shortened synthesis using paraformaldehyde or trioxane
Lapsed on the fee record
Ended Feb 14, 2024 · From the USPTO record
Lapsed on the fee recordEnded Feb 14, 2024From the USPTO record
US 6,858,650Stable Salts of Novel Derivatives of 3,3-Diphenylpropylamines
Term ended
Ended no later than Jan 8, 2024 · Medium confidence
Term endedEnded no later than Jan 8, 2024Medium confidence
US 9,186,335Hot melt TTS for administering rotigotine
Formerly held
Lapsed on the fee record
Ended Nov 17, 2023 · From the USPTO record
Lapsed on the fee recordEnded Nov 17, 2023From the USPTO record
US 7,985,873Synthesis of phenolic esters of hydroxymethyl phenols
Lapsed on the fee record
Ended Jul 26, 2023 · From the USPTO record
Lapsed on the fee recordEnded Jul 26, 2023From the USPTO record
US 10,322,093Method for producing a transdermal therapeutic system which contains a D2 agonist
Formerly held
Term ended
Term ended Sep 22, 2022 · From the USPTO record
Term endedTerm ended Sep 22, 2022From the USPTO record
US 7,632,859Iontophoretic delivery of rotigotine for the treatment of Parkinson's disease
Lapsed on the fee record
Ended Dec 15, 2021 · From the USPTO record
Lapsed on the fee recordEnded Dec 15, 2021From the USPTO record
US 6,884,434Transdermal therapeutic system which contains a d2 agonist and which is provided for treating parkinsonism, and a method for the production thereof
Formerly held
Term ended
Term ended Mar 30, 2021 · From the USPTO record
Term endedTerm ended Mar 30, 2021From the USPTO record
10 of 80 patents shown.
Pro members see all 80.
Pro members: see all 80 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited